Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7XQV

The complex of nanobody Rh57 binding to GTP-bound RhoA active form

Summary for 7XQV
Entry DOI10.2210/pdb7xqv/pdb
DescriptorRhoA, Rh57, ALANINE, ... (6 entities in total)
Functional Keywordsprotein binding
Biological sourceRattus norvegicus
More
Total number of polymer chains2
Total formula weight37542.13
Authors
Zhang, Y.R.,Liu, R.,Ding, Y. (deposition date: 2022-05-09, release date: 2022-07-13, Last modification date: 2024-10-30)
Primary citationZhang, Y.,Cheng, S.,Zhong, P.,Wang, Z.,Liu, R.,Ding, Y.
Structural insights into the binding of nanobody Rh57 to active RhoA-GTP.
Biochem.Biophys.Res.Commun., 616:122-128, 2022
Cited by
PubMed Abstract: RhoA protein is a small GTPase that acts as a molecular switch. When bound to guanosine triphosphate (GTP), RhoA can activate several key signal pathways. Recently, nanobody Rh57 specific binding with GTP bound active RhoA was discovered and developed as a BRET biosensor without cytotoxicity. To further clarify the nanobody Rh57's mechanism of action, we co-expressed, purified, and crystallized the RhoA-Rh57 nanobody complex and solved the structure by X-ray diffraction with a resolution of 2.76 Å. The structure showed that the interaction is mainly through hydrogen bonds, salt bridges, aromatic-aromatic interactions, and hydrophobic interactions. The involved regions include CDR3 and non-hypervariable loop of Rh57, and the SWI switch loops of RhoA, respectively. The different SWI conformation of inactivated RhoA-GDP prevented the Rh57's binding. The possible explanation of Rh57 as a non-cytotoxic BRET intracellular tracer is that Rh57's binding did not overlap with downstream PRK1 and thus did not interfere with the downstream signaling pathway. Our research provides an in-depth understanding of how nanobodies recognize activated RhoA-GTP while not binding inactivated RhoA-GDP. This structural information may also provide critical information for further optimization of relevant nanobodies.
PubMed: 35665664
DOI: 10.1016/j.bbrc.2022.05.084
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.76 Å)
Structure validation

227933

PDB entries from 2024-11-27

PDB statisticsPDBj update infoContact PDBjnumon